Potential role of GcMAF in suppressing the severity of COVID-19-induced immune responses: Lesson learned from HIV

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Medical Hypotheses

• Publication date

  2020-09-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.mehy.2020.110293PMID 33254486PMCID 7513798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer

  2020cited by this paper
• Of chloroquine and COVID-19

  2020cited by this paper
• Clinical Characteristics of Coronavirus Disease 2019 in China

  2020cited by this paper
• Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

  2020cited by this paper
• Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia

  2020cited by this paper
• Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome

  2020cited by this paper
• Letter to the Editor: Lipemic serum in patients with COVID-19 undergoing treatment.

  2020cited by this paper
• Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia

  2020cited by this paper
• Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D

  2020cited by this paper
• Current pharmacological treatments for COVID‐19: What's next?

  2020cited by this paper
• Sex and Gender Disparities in the COVID-19 Pandemic

  2020cited by this paper
• SARS-CoV-2 and viral sepsis: observations and hypotheses

  2020cited by this paper
• Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies

  2020cited by this paper
• Hematological findings and complications of COVID‐19

  2020cited by this paper
• Re. “Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): rationale and feasibility of a shared pragmatic protocol”

  2020cited by this paper
• COVID-19 Autopsies, Oklahoma, USA

  2020cited by this paper
• Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths

  2020cited by this paper
• Treatment options for COVID-19: The reality and challenges

  2020cited by this paper
• Coronavirus disease 2019 (COVID-19): a clinical update

  2020cited by this paper
• Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

  2020cited by this paper
• A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses

  2020influential reference
• Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

  2020cited by this paper
• Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

  2020cited by this paper
• Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.

  2020cited by this paper
• Pathological findings of COVID-19 associated with acute respiratory distress syndrome

  2020cited by this paper
• Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

  2020cited by this paper
• Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside

  2017cited by this paper
• Is α-N-acetylgalactosaminidase the key to curing cancer? A mini-review and hypothesis.

  2017cited by this paper
• Investigation of Vitamin D-Binding Protein Polymorphism Impact on Coronary Artery Disease and Relationship with Longevity: Own Data and a Review

  2016cited by this paper
• Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?

  2016cited by this paper
• Case Report: GcMAF Treatment in a Patient with Multiple Sclerosis.

  2016cited by this paper
• Current and emerging treatment options in the management of lupus

  2016cited by this paper
• Is chondroitin sulfate responsible for the biological effects attributed to the GC protein-derived Macrophage Activating Factor (GcMAF)?

  2016cited by this paper
• Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?

  2016cited by this paper
• Degalactosylated/Desialylated Bovine Colostrum Induces Macrophage Phagocytic Activity Independently of Inflammatory Cytokine Production.

  2015cited by this paper
• Vitamin D binding protein gene polymorphisms and chronic obstructive pulmonary disease: a meta-analysis.

  2015cited by this paper
• Oral Colostrum Macrophage-activating Factor for Serious Infection and Chronic Fatigue Syndrome: Three Case Reports.

  2015influential reference
• The use of Gc protein-derived macrophage activating factor for management of thyroid cancer.

  2015cited by this paper
• Case report: A breast cancer patient treated with GcMAF, sonodynamic therapy and hormone therapy.

  2014cited by this paper
• Oleic Acid, deglycosylated vitamin D-binding protein, nitric oxide: a molecular triad made lethal to cancer.

  2014cited by this paper
• Circulating complexes of the vitamin D binding protein with G-actin induce lung inflammation by targeting endothelial cells.

  2014cited by this paper
• THERAPEUTIC EFFECTS OF HIGHLY PURIFIED DE-GLYCOSYLATED GCMAF IN THE IMMUNOTHERAPY OF PATIENTS WITH CHRONIC DISEASES

  2013cited by this paper
• Clinical experience of integrative cancer immunotherapy with GcMAF.

  2013cited by this paper
• Vascular Endothelial Growth Factor in Acute Lung Injury and Acute Respiratory Distress Syndrome

  2013cited by this paper
• Effect of paricalcitol and GcMAF on angiogenesis and human peripheral blood mononuclear cell proliferation and signaling.

  2012cited by this paper
• GcMAF : our next-generation immunotherapy

  2012cited by this paper
• Initial Observations of elevated Alpha-n-Acetylgalactosaminidase Activity Associated with Autism and Observed Reductions from GC Protein—Macrophage Activating Factor Injections

  2012cited by this paper
• Retracted: Immunotherapy of HIV‐infected patients with Gc protein‐derived macrophage activating factor (GcMAF)

  2009cited by this paper
• Tocilizumab: a review of its use in the management of rheumatoid arthritis.

  2009cited by this paper
• Ocular Toxicity of Hydroxychloroquine

  2008cited by this paper
• Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF.

  2008cited by this paper
• Pathogenic Significance of α-N-Acetylgalactosaminidase Activity Found in the Envelope Glycoprotein gp160 of Human Immunodeficiency Virus Type 1

  2006cited by this paper
• Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential.

  2006cited by this paper
• Ocular toxicity of hydroxychloroquine.

  2006cited by this paper
• Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the envelope glycoprotein gp160 of human immunodeficiency virus Type 1.

  2006cited by this paper
• Vitamin D physiology.

  2006cited by this paper
• Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity.

  2005cited by this paper
• Extracellular superoxide dismutase.

  2005cited by this paper
• Pathogenic significance of α-N-acetylgalactosaminidase activity found in the hemagglutinin of influenza virus

  2005cited by this paper
• Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro

  2004cited by this paper
• Mitogen‐activated protein kinase pathway mediates DBP–maf‐induced apoptosis in RAW 264.7 macrophages

  2003cited by this paper
• Plasma concentration of Gc-globulin is associated with organ dysfunction and sepsis after injury

  2003cited by this paper
• Changes with malnutrition in the concentration of plasma vitamin D binding protein in growing rats

  2002cited by this paper
• Effects of vitamin D(3)-binding protein-derived macrophage activating factor (GcMAF) on angiogenesis.

  2002cited by this paper
• Changes with malnutrition in the concentration of plasma vitamin D binding protein in growing rats.

  2002cited by this paper
• Deglycosylation of serum vitamin D3-binding protein by alpha-N-acetylgalactosaminidase detected in the plasma of patients with systemic lupus erythematosus.

  1997cited by this paper
• Defective lymphocyte glycosidases in the macrophage activation cascade of juvenile osteopetrosis.

  1996cited by this paper
• Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients.

  1996cited by this paper
• Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats.

  1996cited by this paper
• Structural Modification of Serum Vitamin D3-Binding Protein and Immunosuppression in AIDS Patients

  1995cited by this paper
• Plasma vitamin D-binding protein (Gc-globulin): multiple tasks.

  1995cited by this paper
• Affinity purification of human plasma vitamin D-binding protein.

  1995cited by this paper
• Coordinated inhibition of actin-induced platelet aggregation by plasma gelsolin and vitamin D-binding protein

  1993cited by this paper
• Coordinated inhibition of actin-induced platelet aggregation by plasma gelsolin and vitamin D-binding protein.

  1993cited by this paper
• Regulation of inflammation-primed activation of macrophages by two serum factors, vitamin D3-binding protein and albumin

  1993cited by this paper
• The extracellular actin-scavenger system and actin toxicity.

  1992cited by this paper
• Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes.

  1991cited by this paper
• Chloroquine intoxication.

  1983cited by this paper
• Chloroquine intoxication [letter]

  1983cited by this paper
• Turnover of the plasma binding protein for vitamin D and its metabolites in normal human subjects.

  1981cited by this paper
• Vitamin D-binding protein (Gc-globulin) binds actin.

  1980cited by this paper
• Comparison of the antiviral activity in vitro of some non-steroidal anti-inflammatory drugs.

  1969cited by this paper
• THE WORLD HEALTH ORGANIZATION

  1954cited by this paper

• Alpha-N-acetylgalactosaminidase in cancer: diagnostic applications and related treatment strategies.

  2025cites this paper
• GcMAF in radiation therapy: identification and molecular characterization of the human GcMAF receptor

  2024cites this paper
• Adjunctive use of oral MAF is associated with no disease progression or mortality in hospitalized patients with COVID-19 pneumonia: The single-arm COral-MAF1 prospective trial.

  2023cites this paper
• Immunotherapy with GcMAF revisited - A critical overview of the research of Nobuto Yamamoto.

  2022cites this paper
• Analysis of the Biological Properties of Blood Plasma Protein with GcMAF Functional Activity

  2022cites this paper
• Some Measures for COVID-19 Including Deep Ultraviolet Light-Emitting Diode (DUV-LED), Gc protein-derived Macrophage-Activating Factor (Gcmaf), and 5-Aminolevulinic Acid (5-ALA)

  2021cites this paper